Carmat's artificial heart looks to cows for efficacy

Carmat is blazing a trail toward a functional artificial heart, and the company's so-far success comes thanks to bovine tissue used to get around the clotting problems that plagued synthetic devices past. As The New York Times reports, Carmat's device has been cleared for human trials in Europe and elsewhere, and researchers say the use of cow tissue could help the device succeed where others have proven ineffective. Bovine tissue isn't new in the medical device world, as many replacement aortic valves incorporate it, but Carmat is the first to put it to use in an artificial heart. More

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.